Pharmaceutical Executive
In some ways the Australian medicines industry is going through the same restructuring and challenges as the industry is globally: the country is dealing with patent cliffs, companies are cutting back staff, an ageing population forces the government to rethink healthcare expenditures, and big originator companies are reforming.
After a decade of strife, the dialogue between industry and government appears to have entered a positive new phase. Julian Upton reports.
Pharmaceutical Executive
After years of asking questions, the National Highway Traffic Safety Administration (NHTSA)is moving closer to a protocol "for assessing the driving-impairment risks of drugs". Ben Comer reports.
Pharmaceutical Executive
Caronia decision shows the staying power of Sorrell v. IMS Health.
Pharm Exec recently convened a cross-section of industry experts to review current and pending efforts to turn great science into good oncology practice.
Pharmaceutical Executive
2013 Oncology Practice Roundtable
